QbD Pharma

QbD Pharmaceutical (Hebei) Co., Ltd. was established in April 2021 in the High-Tech Development Zone of Shijiazhuang City, and moved to Cangzhou Economic Development Zone in September 2023, serving as the parent company of the entire Suibidi group system. Its core functions are corporate development planning, product strategy research, marketing management, and investment and financing management. Hebei QbD Pharmaceutical Technology Co., Ltd. was established in March 2018 in the national economic and technological development zone of Cangzhou, and officially started business in October 2019. It moved to Cangzhou Economic Development Zone in February 2022, serving as a professional CRO (contract research organization) company for drugs. Its core function is to undertake commissioned research and development business. QbD Pharmaceutical (Cangzhou) Co., Ltd. was established in October 2021 in Cangzhou Economic Development Zone, serving as one of the regional subsidiaries of the QbD group system. Its core function is the research and development of proprietary or cooperative products, as well as the production and sales of raw materials and high-end injection products (vial water injection, lyophilized powder injection, and pre-filled injection), and oral solid dosage forms.